Occupational stress trajectories and metabolic dysfunction–associated steatotic liver disease among female nurses: a prospective Cohort Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Occupational stress trajectories and metabolic dysfunction–associated steatotic liver disease among female nurses: a prospective Cohort Study ; volume:24 ; number:1 ; day:16 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
BMC public health ; 24, Heft 1 (16.11.2024), 1-11, 12.2024
- Creator
-
Luo, Hanxiao
Xing, Linlin
Fu, Tongtong
Xiao, Shiqi
Fan, Ling
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-20742-z
- URN
-
urn:nbn:de:101:1-2502040904522.316265743581
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Hanxiao
- Xing, Linlin
- Fu, Tongtong
- Xiao, Shiqi
- Fan, Ling
- SpringerLink (Online service)
Other Objects (12)
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics